HIGHLIGHTS
- who: Hongqing Zhou from the Frontiers Media SA, SwitzerlandThe Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China have published the paper: Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells, in the Journal: (JOURNAL)
SUMMARY
The targeting protein for Xklp2, prostate carcinoma, E26 transformation specific sequence 1, metastasis, endocrine-independent A Corrigendum on TPX2 enhanced the Activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-Independent prostate carcinoma cells by Zhou Q . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.